Evidence map›Paper›PMID 36277678›Full record

ArticleDiscovery immunology2022

NKG2D signaling regulates IL-17A-producing γδT cells in mice to promote cancer progression.

Sophie Curio, Sarah C Edwards, Toshiyasu Suzuki, Jenny McGovern, Chiara Triulzi, Nagisa Yoshida, Gustav Jonsson, Teresa Glauner, Damiano Rami, Robert Wiesheu and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Discovery immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Sophie CurioDepartment of Life Sciences, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-7991-9241
Sarah C EdwardsInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Toshiyasu SuzukiInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Jenny McGovernDepartment of Life Sciences, Imperial College London, London, UK.
Chiara TriulziDepartment of Life Sciences, Imperial College London, London, UK.
Nagisa YoshidaDepartment of Life Sciences, Imperial College London, London, UK.
Gustav JonssonDepartment of Life Sciences, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-6692-8395
Teresa GlaunerInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Damiano RamiInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Robert WiesheuInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Anna KilbeyInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Rachel Violet PurcellDepartment of Surgery, University of Otago, Christchurch, New Zealand.
Seth B CoffeltInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.ORCID https://orcid.org/0000-0003-2257-2862
Nadia GuerraDepartment of Life Sciences, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-6159-1241
Cancer Research UK Scotland Institute · GBImperial College London · GBUniversity of Otago · NZ

Funding

Breast Cancer Now 2018JULPR1101Wellcome Trust
6 · The paper itself

Abstract

γδT cells are unconventional T cells particularly abundant in mucosal tissues that play an important role in tissue surveillance, homeostasis, and cancer. γδT cells recognize stressed cells or cancer cells through the NKG2D receptor to kill these cells and maintain normality. Contrary to the well-established anti-tumor function of these NKG2D-expressing γδT cells, we show here that, in mice, NKG2D regulates a population of pro-tumor γδT cells capable of producing IL-17A. Germline deletion of

Indexed as

inflammationNKG2Dtumor immunologyγδT cells

Identifiers

PMID36277678
PMCPMC9580227
OpenAlexW4280645459

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.